LoveBScott on MSN
The States Who Are Protecting PrEP Against All Odds
Over the past several years, the Trump administration has cut critical funding for HIV research and has sought to limit ...
The application relies on the clinical profile established in the phase 3 PURPOSE 1 and PURPOSE 2 trials, which demonstrated superior efficacy in reducing incident HIV-1 infections.
ATLANTA — Five years ago, the U.S. government unveiled a plan to end the HIV epidemic by 2030. More than 30,000 people are diagnosed with HIV every year in this country. But this is not a problem for ...
Hosted on MSN
Is PrEP Right for You? A No-Nonsense Guide for Women and Men Considering the Medication
When it comes to HIV prevention, few tools have been as game-changing as PrEP — short for pre-exposure prophylaxis. Yet, despite its effectiveness, many people still aren’t sure whether it’s right for ...
After nearly a decade of working as an advocate for HIV and AIDS treatment, Michael Chancley said he came to a sobering realization. “Seeing that people who look like me, who hang out at the same ...
People at risk for contracting HIV from sex can reduce their risk of infection by up to 99% when they take pre-exposure prophylaxis (PrEP), an antiretroviral medication, as directed. However, most ...
Though you can go to a doctor’s office to get PrEP, there are also some telemedicine services where you can get a prescription for PrEP online. See our picks below, along with other tips on finding ...
Public health messaging that drives stigma around pre-exposure prophylaxis (PrEP), a medication that can reduce HIV risk by up to 99%, appears to play a role in uptake of the medication. While the ...
See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. A new pre-exposure prophylaxis (PrEP) drug has shown promise as a ...
Add Yahoo as a preferred source to see more of our stories on Google. New Trump administration rules on foreign assistance are prohibiting U.S.-backed programs from delivering HIV prevention drugs to ...
The Akwa Ibom government has launched the Long-Acting Pre-Exposure Prophylaxis, LENACAPAVIR (LEN-PrEP) drug, a new HIV ...
Sara Moniuszko is a health and lifestyle reporter at CBSNews.com. Previously, she wrote for USA Today, where she was selected to help launch the newspaper's wellness vertical. She now covers breaking ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results